TrialThorax2016

Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial.

John F Fraser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.